Correlation Between Amylyx Pharmaceuticals and Krystal Biotech

Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amylyx Pharmaceuticals and Krystal Biotech, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Krystal Biotech.

Diversification Opportunities for Amylyx Pharmaceuticals and Krystal Biotech

0.72

Correlation Coefficient

Amylyx Pharmaceuticals  Krystal Biotech

Poor diversification

The 3 months correlation between Amylyx and Krystal is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Krystal Biotech go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Krystal Biotech

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to under-perform the Krystal Biotech. In addition to that, Amylyx Pharmaceuticals is 1.35 times more volatile than Krystal Biotech. It trades about -0.2 of its total potential returns per unit of risk. Krystal Biotech is currently generating about -0.03 per unit of volatility. If you would invest  19,742  in Krystal Biotech on November 29, 2024 and sell it today you would lose (1,632) from holding Krystal Biotech or give up 8.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Amylyx Pharmaceuticals  vs.  Krystal Biotech

Amylyx Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amylyx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's essential indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the ETF investors.

Krystal Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Amylyx Pharmaceuticals and Krystal Biotech

The main advantage of trading using opposite Amylyx Pharmaceuticals and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.

The idea behind Amylyx Pharmaceuticals and Krystal Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.